Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-14 10:08 am Sale | 2022-12-31 | 13G | iTeos Therapeutics, Inc. ITOS | RTW Investments, LP | 0 0.000% | -2,353,015 (Position Closed) | Filing History |
| 2023-02-14 10:07 am Purchase | 2022-12-31 | 13G | PMV Pharmaceuticals, Inc. PMVP | RTW Investments, LP | 4,356,920 9.500% | 1,375,960 (+46.16%) | Filing History |
| 2023-02-14 10:07 am Purchase | 2022-12-31 | 13G | Axsome Therapeutics, Inc. AXSM | RTW Investments, LP | 2,980,482 6.900% | 2,980,482 (New Position) | Filing History |
| 2023-02-14 10:07 am Purchase | 2022-12-31 | 13G | Jounce Therapeutics, Inc. JNCE | RTW Investments, LP | 5,106,341 9.900% | 2,243,143 (+78.34%) | Filing History |
| 2023-02-14 10:06 am Purchase | 2022-12-31 | 13G | Immunic, Inc. IMUX | RTW Investments, LP | 3,861,290 8.700% | 2,145,820 (+125.09%) | Filing History |
| 2023-02-14 10:06 am Sale | 2022-12-31 | 13G | La Jolla Pharmaceutical Company LJPC | RTW Investments, LP | 0 0.000% | -2,590,932 (Position Closed) | Filing History |
| 2023-02-14 10:06 am Sale | 2022-12-31 | 13G | IVERIC bio, Inc. ISEE | RTW Investments, LP | 821,288 0.600% | -5,901,336 (-87.78%) | Filing History |
| 2023-02-14 10:06 am Purchase | 2022-12-31 | 13G | Prometheus Biosciences, Inc. RXDX | RTW Investments, LP | 3,354,303 7.200% | 90,272 (+2.77%) | Filing History |
| 2023-02-14 10:05 am Purchase | 2022-12-31 | 13G | Oyster Point Pharma, Inc. OYST | RTW Investments, LP | 2,304,977 8.600% | 246,473 (+11.97%) | Filing History |
| 2023-02-14 10:05 am Purchase | 2022-10-31 | 13G | Immunocore Holdings plc IMCR | RTW Investments, LP | 5,559,322 12.300% | 5,559,322 (New Position) | Filing History |
| 2023-02-14 10:04 am Purchase | 2022-12-31 | 13G | Fulcrum Therapeutics, Inc. FULC | RTW Investments, LP | 4,993,279 9.600% | 1,126,407 (+29.13%) | Filing History |
| 2023-02-14 10:04 am Purchase | 2022-12-31 | 13G | Protagonist Therapeutics, Inc. PTGX | RTW Investments, LP | 3,591,986 7.300% | 992,164 (+38.16%) | Filing History |
| 2023-02-14 10:04 am Sale | 2022-12-31 | 13G | ESSA Pharma Inc. EPIX | RTW Investments, LP | 0 0.000% | -2,637,192 (Position Closed) | Filing History |
| 2023-02-14 10:03 am Purchase | 2022-12-31 | 13G | Establishment Labs Holdings Inc. ESTA | RTW Investments, LP | 2,374,138 9.800% | 55,000 (+2.37%) | Filing History |
| 2023-02-14 10:02 am Purchase | 2022-12-31 | 13G | PTC Therapeutics, Inc. PTCT | RTW Investments, LP | 5,615,387 7.700% | 321,421 (+6.07%) | Filing History |
| 2023-02-14 10:02 am Purchase | 2022-12-31 | 13G | CUTERA INC CUTRQ | RTW Investments, LP | 1,798,675 9.200% | 401,612 (+28.75%) | Filing History |
| 2023-02-14 10:01 am Sale | 2022-12-31 | 13G | Avadel Pharmaceuticals plc AVDL | RTW Investments, LP | 5,741,939 9.300% | -68,201 (-1.17%) | Filing History |
| 2023-02-14 10:01 am Purchase | 2022-12-31 | 13G | Exagen Inc. XGN | RTW Investments, LP | 1,364,336 8.400% | 542,922 (+66.10%) | Filing History |
| 2023-02-14 10:01 am Purchase | 2022-12-31 | 13G | Adicet Bio, Inc. ACET | RTW Investments, LP | 4,241,472 9.900% | 1,217,728 (+40.27%) | Filing History |
| 2023-02-14 10:00 am Sale | 2022-12-31 | 13G | Pyxis Oncology, Inc. PYXS | RTW Investments, LP | 0 0.000% | -2,120,760 (Position Closed) | Filing History |